Published in Diabetes Care on October 06, 2009
Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care (2010) 3.12
Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care (2010) 2.38
Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin. Diabetes (2011) 1.44
Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care (2011) 1.38
Prediabetes as a therapeutic target. Clin Chem (2010) 1.01
We can change the natural history of type 2 diabetes. Diabetes Care (2014) 0.91
Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults. Obesity (Silver Spring) (2013) 0.89
Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes. Am J Physiol Endocrinol Metab (2013) 0.89
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention. Drugs (2015) 0.86
Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients. Br J Clin Pharmacol (2015) 0.82
Metformin-induced hepatotoxicity. Diabetes Care (2012) 0.81
Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance. Cardiol Ther (2016) 0.80
Glycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55-64 Years. Psychosom Med (2015) 0.79
Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice. J Endocrinol (2014) 0.78
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients. Cardiovasc Diabetol (2014) 0.78
Diabetes: preventing type 2 diabetes mellitus: is metformin the answer? Nat Rev Endocrinol (2010) 0.77
Proximal correlates of metabolic phenotypes during 'at-risk' and 'case' stages of the metabolic disease continuum. Nutr Diabetes (2012) 0.76
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Economic costs of diabetes in the U.S. In 2007. Diabetes Care (2008) 15.73
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care (2008) 10.90
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet (2002) 9.48
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med (2005) 6.63
Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care (2007) 6.24
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet (2002) 5.77
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet (2007) 5.74
XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care (2004) 5.34
UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia (1991) 4.50
The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr (2005) 3.61
The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes (2003) 3.23
Skeletal consequences of thiazolidinedione therapy. Osteoporos Int (2007) 1.42
Glucose challenge test screening for prediabetes and undiagnosed diabetes. Diabetologia (2009) 1.22
Natural history of impaired glucose tolerance: follow-up at Joslin Clinic. Diabet Med (1996) 1.21
Considerations for management of fluid dynamic issues associated with thiazolidinediones. Am J Med (2003) 1.11
Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab. Diabetes Care (2006) 0.94
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA (2005) 8.07
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med (2006) 7.32
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet (2009) 6.83
Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med (2004) 6.77
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet (2008) 6.72
The evolving diabetes burden in the United States. Ann Intern Med (2004) 6.36
Incidence of childhood obesity in the United States. N Engl J Med (2014) 6.07
A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med (2002) 5.64
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med (2010) 4.87
Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med (2007) 4.64
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet (2005) 4.45
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2012) 4.45
Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34
Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol (2002) 4.18
Relationship of walking to mortality among US adults with diabetes. Arch Intern Med (2003) 3.95
It's time to overcome clinical inertia. Ann Intern Med (2008) 3.85
Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med (2012) 3.85
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med (2004) 3.78
Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care (2006) 3.67
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA (2012) 3.66
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65
Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA (2004) 3.48
Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry (2003) 3.48
Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol (2012) 3.47
Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26
Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials (2008) 3.24
Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol (2003) 3.19
Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care (2010) 3.12
Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol (2012) 2.93
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol (2010) 2.86
Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure. Circulation (2005) 2.85
Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics (2005) 2.85
Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Circulation (2005) 2.80
Patient adherence improves glycemic control. Diabetes Educ (2005) 2.69
Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med (2015) 2.64
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation (2008) 2.53
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation (2014) 2.50
Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 2.50
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol (2010) 2.49
A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag Sci (2003) 2.47
Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation (2003) 2.45
Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail (2003) 2.45
Predictors of medication self-management skill in a low-literacy population. J Gen Intern Med (2006) 2.40
Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc (2008) 2.38
An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8. Arch Intern Med (2006) 2.37
Aging, retirement, and changes in physical activity: prospective cohort findings from the GLOBE study. Am J Epidemiol (2007) 2.36
Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail (2008) 2.33
Caloric sweetener consumption and dyslipidemia among US adults. JAMA (2010) 2.30
Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol (2003) 2.30
Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA (2011) 2.29
Health of foreign-born people in the United States: a review. Health Place (2008) 2.29
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care (2003) 2.29
Considerations for diabetes translational research in real-world settings. Diabetes Care (2003) 2.26
Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care (2002) 2.24
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Association between promoter methylation of serotonin transporter gene and depressive symptoms: a monozygotic twin study. Psychosom Med (2013) 2.19
The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18
Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am J Epidemiol (2004) 2.18
Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Arch Intern Med (2008) 2.16
Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care (2007) 2.16
Race and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. Ethn Dis (2007) 2.15
Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol (2008) 2.14
Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med (2002) 2.12
Socioeconomic status and diagnosed diabetes incidence. Diabetes Res Clin Pract (2005) 2.08
Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation (2011) 2.08
Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care (2008) 2.07
The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease. Eur Heart J (2010) 2.04